Articles | Volume 9, issue 5
https://doi.org/10.5194/jbji-9-213-2024
https://doi.org/10.5194/jbji-9-213-2024
Case report
 | 
07 Oct 2024
Case report |  | 07 Oct 2024

Efficacy of rezafungin in a case of Candida spondylodiskitis

Marin Lahouati, Claire Tinévez, Frédéric Gabriel, Fabien Xuereb, Maxime Lefranc, and Frédéric-Antoine Dauchy

Viewed

Total article views: 442 (including HTML, PDF, and XML)
HTML PDF XML Total BibTeX EndNote
343 60 39 442 15 15
  • HTML: 343
  • PDF: 60
  • XML: 39
  • Total: 442
  • BibTeX: 15
  • EndNote: 15
Views and downloads (calculated since 07 Oct 2024)
Cumulative views and downloads (calculated since 07 Oct 2024)

Viewed (geographical distribution)

Total article views: 427 (including HTML, PDF, and XML) Thereof 427 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 

Cited

Latest update: 01 Apr 2025
Download
Short summary
This work outlines the first case study of Candida glabrata bone and joint infection successfully treated with 3 weeks of caspofungin followed by 10 weeks of rezafungin, a new generation of antifungal treatment, using a weekly administration mode. 
Share